|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 12 December 2006
doi: 10.1242/jcs.03317
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
1 Department of Molecular and Microbial Pathogenesis, College of Medicine, Texas A&M Health Science Center, College Station, TX 77843-1114, USA
2 Department of Molecular Genetics and Microbiology, and of Obstetrics and Gynecology, University of New Mexico School of Medicine, 915 Camino de Salud NE, Cancer Research Facility (CRF) 303, Albuquerque, NM 87131, USA
* Author for correspondence (e-mail: wilson{at}medicine.tamhsc.edu)
Accepted 25 October 2006
| Summary |
|---|
|
|
|---|
Key words: Keratinocyte, Differentiation, SUMO, HaCaT, Ubc9
| Introduction |
|---|
|
|
|---|
SUMO modification usually exerts significant effects on its targets: it can increase protein stability (Desterro et al., 1998
), affect protein-protein interactions (Seeler and Dejean, 2001
), alter subcellular localization (Morita et al., 2005
; Wilson and Rangasamy, 2001
), and impact nuclear trafficking (Pichler and Melchior, 2002
). To date, transcription factors (TFs) represent the largest group of SUMO substrates identified, and the most common effect associated with TF sumoylation is modulation of their transcriptional activity (Gill, 2003
; Verger et al., 2003
). In general, sumoylation results in the negative regulation of the activity of most TFs, including widely expressed factors such as AP-1 (Bossis et al., 2005
), Sp1/Sp3 (Ross et al., 2002
; Spengler and Brattain, 2006
), and C/EBP (Kim et al., 2002
), though activation has been reported for some TFs, including TCF4 (Ihara et al., 2005
) and IKaros (Arco et al., 2005
). Recent studies have established multiple mechanisms for negative regulation of TFs by sumoylation, including recruitment of transcriptional co-repressors such as HDACs (Shiio and Eisenman, 2003
; Yang and Sharrocks, 2004
), sequestration in the cytoplasm (Morita et al., 2005
; Salinas et al., 2004
) or ubiquitylation and subsequent degradation (Ghioni et al., 2005
).
Many of the TFs known to be SUMO targets, including pRB (Ledl et al., 2005
), the p53/63/73 family (Ghioni et al., 2005
; Melchior and Hengst, 2002
), AP-2 (Eloranta and Hurst, 2002
), and Sp1/Sp3 (Ross et al., 2002
; Spengler and Brattain, 2006
) are involved in regulating gene expression during cell-cycle progression and/or differentiation (Herwig and Strauss, 1997
; Li and Kellems, 2003
; Santini et al., 2001
), suggesting that sumoylation could coordinate complex transcriptional programs in the cell. Several recent studies in metazoan systems support such a role for sumoylation in aspects of development and differentiation. Sumoylation is required for correct vulvar development in C. elegans (Leight et al., 2005
; Poulin et al., 2005
), is implicated in male germ cell maturation (Vigodner et al., 2006
) and promotes differentiation of postsynaptic dendrites (Shalizi et al., 2006
). Sumoylation is also critical for maintaining nuclear structure and chromosomal segregation during blastocyst development, with the absence of Ubc9 leading to an embryonic lethal phenotype (Nacerddine et al., 2005
).
Skin is a complex and renewable organ for which little is known about the expression and function of the sumoylation system, although the presence of the SUMO1 protein in a mouse keratinocyte cell line has been reported (Zhong et al., 2000
). The epidermis comprises multiple layers of differentiated keratinocytes that are continually regenerated from the replicative basal layer. In skin, keratinocytes differentiate vertically because of a Ca2+ gradient established throughout the different epithelial layers, increasing from the basal to the outermost layer of the epithelium (Menon et al., 1985
; Vicanova et al., 1998
). Ca2+ signaling drives proliferating keratinocytes out of the cell cycle and into a committed path of terminal differentiation, but the intermediate signaling transduction pathways that lead to this process are still poorly understood (Bikle et al., 2001
; Lansdown, 2002
; Tu et al., 2004
). A network of keratin markers biochemically defines the keratinocyte stage within the epithelium structure (Eichner et al., 1986
; Smith, 2003
; Sun et al., 1985
). Expression of keratin 5 (K5) and keratin 14 (K14) characterizes the basal proliferative phenotype restricted to the stem cell layer where the Ca2+ concentration is low (Schweizer and Winter, 1983
). Early in differentiation, K5 and K14 are repressed and differentiation markers such as K1, K10 and involucrin begin to be expressed. Finally, keratinocytes complete terminal differentiation by producing the outer cornified layer of the skin characterized by markers such as filaggrin and involucrin (Candi et al., 2005
; Eichner et al., 1986
; Fuchs and Green, 1980
). This pattern of markers permits discrimination between proliferating, differentiating and terminally differentiated keratinocytes. The well-coordinated expression of specific sets of TFs induces and represses these keratinocyte genes as the cells migrate through the epithelium layers, and a number of these crucial TFs are already known to be SUMO targets in other tissues (Girdwood et al., 2004
; Verger et al., 2003
), suggesting that sumoylation might play an important role in regulating epidermal differentiation.
Cultured keratinocytes, such as HaCaT cells, provide well-established differentiation models that can recapitulate many aspects of stratified epithelium (Boukamp et al., 1988
; Schoop et al., 1999
). HaCaTs are spontaneously immortalized and do not express exogenous transforming genes that could interfere with the natural process of sumoylation and differentiation. Moreover, HaCaT cells have the capacity to revert back and forth between the differentiated and the basal phenotype, and therefore are widely used to model keratinocyte differentiation in culture (Schoop et al., 1999
). Here, we examine the sumoylation system in HaCaT cells during Ca2+-induced differentiation. We show that the sumoylation system was transiently upregulated by Ca2+ signaling in HaCaT cells at both the RNA and protein level, whereas abrogation of sumoylation led to abnormal differentiation. These results suggest cross talk between the sumoylation system and the keratinocyte differentiation process that contributes to the normal program of morphological and biochemical changes during differentiation.
| Results |
|---|
|
|
|---|
|
14-fold higher levels of involucrin mRNA in the high [Ca2+]-maintained keratinocytes compared with the low [Ca2+] culture, confirming the differentiation state of these cells (Fig. 2A). By RT-PCR, transcripts for all of the SUMO component genes were detected in both the basal and differentiated HaCaT cells, indicating that the relevant genes for an active sumoylation system were actively transcribed in both cell populations (Fig. 2B). Although the HaCaT cells were maintained in two distinct phenotypic states, the transcript levels for the sumoylation components tested were similar under both culture conditions (Fig. 2C). Immunoblot analyses confirmed the expression of Ubc9 and SAE1 proteins, and the levels of each of these proteins were only slightly higher in the differentiated cells compared with the undifferentiated HaCaT cells (Fig. 2D). Next, we tested whether the sumoylation system was active in HaCaT cells as evidenced by the presence of sumoylated proteins. Immunoblotting of total cell extracts using a polyclonal anti-SUMO antibody showed that sumoylation occurred in both the basal and differentiated cell populations (Fig. 2E). Although the differences in expression levels of the sumoylation components were small, the sumoylation patterns in differentiated versus basal cells were slightly different: bands at
40, 60 and 95 kDa were intensified in high [Ca2+] cells compared with basal cells (Fig. 2E, arrows). Since the basal and differentiated cell cultures were both equally proliferative and were generated from a single stock of HaCaT cells, we believe that these changes in sumoylation pattern reflect differentiation-related events rather than intrinsic differences in genetic background or growth capacity of the two populations of cells.
|
SUMO and Ubc9 are expressed in stratified human foreskin keratinocytes
To corroborate the HaCaT observations, the expression of SUMO and Ubc9 was evaluated in primary human foreskin keratinocytes (HFKs) that were stratified in organotypic cultures. Immunohistochemistry analyses were performed with an anti-SUMO polyclonal antiserum and a purified polyclonal antibody against Ubc9, and antibody specificity was confirmed by blocking experiments using purified SUMO1 or Ubc9 (Fig. 3). SUMO was detected in the nucleus and cytoplasm of keratinocytes found in all layers of the epithelium (Fig. 3C). However, as this antiserum crossreacts with SUMO2/3 (our unpublished observations), which SUMO types were present and whether or not there were changes in type expression in different layers is unclear. By contrast, Ubc9 was barely detectable in the basal layer of the epithelium where the cells remained relatively unstained (Fig. 3A, arrowheads). Strong anti-Ubc9 staining was detected in the intermediate differentiated layers just above the basal layer, and Ubc9 was present in both the nucleus and cytoplasm of the keratinocytes in this region (Fig. 3A, black arrows). Although Ubc9 could be detected in nuclei throughout the upper layers (Fig. 3A and data not shown), its overall expression faded as keratinocytes moved closer to the outer layer of the epithelium. It appears from these results that Ubc9 expression is low in basal cells, transiently increases with the initiation of differentiation in the suprabasal layers, and declines as terminal differentiation progresses. As Ubc9 is the only E2 enzyme for sumoylation, we speculate that the pool of sumoylated protein might be dramatically altered as well during this process. Interestingly, Ubc9 expression is maximal in the layers just below where keratin 1 expression commences (compare Fig. 3A with 3E). Overall, these analyses demonstrate that sumoylation components are present in stratified human skin epithelium and that Ubc9 levels change during differentiation. The similar observations in HaCaT cultures suggest that monolayer HaCaT cells are a good representative model of the sumoylation system in normal human keratinocytes.
|
|
Transcriptional upregulation of sumoylation by Ca2+ is accompanied by increases in the corresponding proteins and overall sumoylation
Increase of specific transcripts during a biological process is not necessarily functionally important unless it is followed by a corresponding increase in protein expression. Immunoblot analyses of representative sumoylation components indicated that the Ubc9, SAE1 and SENP1 proteins levels remained relatively constant in uninduced cultures over the 6-day incubation period (Fig. 5B,C). By contrast, all three of these proteins were rapidly, but transiently, upregulated more than threefold during HaCaT cell differentiation (Fig. 5B,C). Maximum protein expression was reached at 48-96 hours post induction and then declined. Although the absolute increases for SAE1, Ubc9 and SENP1 were slightly different, the overall expression pattern was similar for all three enzymes (Fig. 5C). Interestingly, although protein expression levels declined 96 hours post induction, transcripts were still elevated and had not begun to decline during the time period examined (Fig. 4C). The explanation for this discordance is not known, but may reflect the existence of a post-transcriptional regulatory mechanism that controls the level of protein expression for the different components of the sumoylation system during keratinocyte differentiation. Nonetheless, the combined results in Figs 2, 4 and 5 indicate that Ca2+ triggers a rapid and coordinated activation of transcription for many SUMO system genes leading to a corresponding accumulation of the SUMO system proteins, eventually followed by a decline to near basal protein levels. The observation in HaCaT cells that there is a transient upregulation of Ubc9 expression strongly correlates with the results from the Ubc9 immunohistochemistry data in the stratified HFKs (Fig. 3), which showed a transient increase in Ubc9 protein levels in the suprabasal layers that declined with further differentiation. Importantly, as in the stratified HFKs, the peak expression of Ubc9 in differentiating HaCaT cells occurred just before expression of the K1 protein (Fig. 5A-C).
|
Next, we wanted to test whether the accumulation of sumoylation components increased the overall population of sumoylated targets. Total cell extracts of Ca2+-induced HaCaT cells were collected every 24 hours up to 144 hours post induction and were analyzed by immunoblotting (Fig. 6). Overall sumoylation was clearly increased between 96 and 144 hours and discernible changes in the sumoylation of specific substrates were observed. During the differentiation process, several substrates (indicated by arrows) showed increased sumoylation, whereas a major sumoylated product at about 70 kDa decreased (arrowhead). In addition, new sumoylated bands appeared at about 45 and 95 kDa (arrows). No changes in substrate sumoylation were observed in parallel cultures maintained in low Ca2+ medium (data not shown). Enhanced sumoylation during HaCaT differentiation was even more pronounced when the samples were evaluated by 2D gel electrophoresis (unpublished observations). These results indicate that the increased expression of the sumoylation components leads to increased sumoylation activity, and that Ca2+-induced differentiation of keratinocytes is accompanied by dynamic changes in the pattern of sumoylated proteins.
|
Inhibition of the sumoylation system perturbs the HaCaT cell differentiation process
To investigate the functional importance of sumoylation in the process of keratinocyte differentiation, we infected basal HaCaT cells with an adenovirus expressing Myc-tagged Gam1 (Ad-Gam1) and then exposed the cells to high [Ca2+] medium to trigger differentiation. Gam1 is known to inhibit sumoylation by inducing degradation of SAE1/2 and Ubc9 (Boggio et al., 2004
). By 24 hours post-infection, Gam1 was detected in HaCaT cells infected with Ad-Gam1, but not in cells infected with Ad-GFP (Fig. 7B). In the Ad-GFP infected cells, the Ubc9 initially present increased 3.2-fold by 48 hours post Ca2+ induction, consistent with the response seen in the absence of viral infection (see Fig. 5B). By contrast, cells expressing Gam1 showed diminished Ubc9 levels by 24 hours and no detectable Ubc9 by 48 hours when Gam1 levels had reached maximal expression. A similar effect was seen in co-infections with Ad-Gam1 and Ad-GFP, indicating that Ad-GFP had no stabilizing effect on Ubc9. In contrast to these infection studies where the transgene could be delivered effectively into nearly 100% of the cells, alternative attempts to inhibit sumoylation via transfection approaches were unsuccessful owing to the poor transfection efficiency of HaCaT cells in low [Ca2+] medium (data not shown).
|
In addition to its inhibition of sumoylation, Gam1 is also known to inhibit HDAC activity (Chiocca et al., 2002
). To exclude the possibility that the observed morphological effects on HaCaT cells could be due to HDAC inhibition, we conducted the Ca2+ induction in the presence of trichostatin A (TSA), a chemical inhibitor of HDACs (Yoshida and Horinouchi, 1999
). Basal HaCaT cells were infected with Ad-GFP, induced with Ca2+, and then treated with 100 mM TSA at 24 hours after induction and infection. GFP expression was prolonged in the TSA-treated cultures compared with the untreated cells, consistent with TSA-mediated enhancement of transcription through HDAC inhibition (data not shown). However, no abnormal morphology was observed during differentiation in TSA, indicating that HDAC inhibition does not contribute to the Gam1 effect on differentiating keratinocytes (Fig. 7A).
|
| Discussion |
|---|
|
|
|---|
One of the salient observations of our studies was the coordinated transcriptional activation of multiple sumoylation genes following exposure of basal HaCaT cells to high [Ca2+] culture conditions. Mechanistically, such coordination could be achieved through common promoter elements responding to Ca2+-induced TFs. High [Ca2+], both in vitro and in vivo, is known to trigger keratinocyte differentiation through multiple signaling pathways that activate a set of effector TFs (Fuchs, 1990
; Sharpe et al., 1989
), which includes NFAT, Sp1, C/EBP and AP1 (Eckert et al., 1997a
; Santini et al., 2001
). Although the promoters for the sumoylation component genes have not been experimentally characterized, bioinformatics analysis (www.genomatrix.de) of the putative promoter regions for the sumoylation genes tested in this study revealed the presence of binding sites for various combinations of the above TFs. There were single NFAT- and AP1-binding sites and three Sp1-binding sites on the SUMO2 promoter; five Sp1-binding sites on the Ubc9 promoter; three C/EBP-binding sites on the SAE1 promoter; and one Sp1-binding site on the predicted SAE2 promoter, consistent with all of these promoters being stimulated concurrently by Ca2+-responsive TFs. Concordantly, SUMO1 transcription exhibited little or no change upon Ca2+ stimulation in HaCaT cells, and analysis of the SUMO1 putative promoter region did not reveal any binding sites for TFs directly activated by Ca2+. Finally, the diversity of TF binding sites on the SUMO system promoters could also account for the quantitatively different transcriptional responses among the SUMO components that did respond to Ca2+ signaling. Detailed promoter studies will be needed to determine which, if any, of these predicted TF binding sites are directly influencing transcriptional expression of the sumoylation genes.
The observed upregulation of the sumoylation system appears to be a transient process associated with active differentiation, because overall transcript and protein levels for the sumoylation components vary only slightly between cells stably maintained in basal versus differentiated conditions (Fig. 2). Since the differentiating HaCaT cells remain normally proliferative, it is likely that the sumoylation changes reflect differentiation-dependent events and not changes related to growth state. We propose a simple model (Fig. 8) for downregulating the sumoylation response based on the known repressive effect that sumoylation exerts on the activity of most TFs (Gill, 2003
). The relevant keratinocyte early differentiation transcription factors, SP1, C/EBP and AP1, are all known to be SUMO targets that are negatively regulated by sumoylation (Bossis et al., 2005
; Eaton and Sealy, 2003
; Spengler and Brattain, 2006
; Terui et al., 2004
). As sumoylation activity increases following transcriptional upregulation of the SUMO pathway genes, it is likely that the above TFs would become SUMO modified and repressed, leading to a decline in transcription of the sumoylation genes. This negative feedback system would dampen the sumoylation response as differentiation progresses resulting in a return to a basal level of sumoylation activity in terminally differentiated cells.
Our transcriptional results also suggest that there are different roles for SUMO2/3 versus SUMO1 in keratinocyte differentiation, because we observed activation of the SUMO2 and SUMO3 promoters, but not of the SUMO1 promoter. Additionally, we observed an increase in SENP1 protein levels during differentiation. SENP1 cleaves the precursor forms of all three SUMOs to produce their mature forms, but also exhibits preferential desumoylating activity for SUMO1-modified substrates compared with SUMO2 and SUMO3 conjugates (Xu and Au, 2005
). The net result of the transcriptional and proteolytic changes may be an overall decrease in SUMO1 conjugates with a corresponding increase in SUMO2 and SUMO3 modified proteins. Although the biological significance of such a change in SUMO type utilization is not known, growing evidence supports distinct functions for SUMO2 and SUMO3 versus SUMO1. It is well established that SUMO1 has only 50% identity with SUMO2 and SUMO3, whereas SUMO2 and SUMO3 are closely related (Saitoh and Hinchey, 2000
). In a recent proteomics study, we demonstrated significant differences between the array of targets modified by SUMO1 versus SUMO3, indicating that these two modifications are not equivalent with regard to substrate preference (Rosas-Acosta et al., 2005b
). Other studies have shown SUMO type-specific differences in cellular localization (Ayaydin and Dasso, 2004
), response to external stimuli (Manza et al., 2004
), and preference for SUMO ligases (Rosas-Acosta et al., 2005a
; Tatham et al., 2005
) and proteases (Gong and Yeh, 2006
; Reverter and Lima, 2004
), reinforcing the concept that the individual SUMOs have both common and unique biological activities. Intriguingly, there is evidence that SUMO1 is more specific for nuclear substrates whereas SUMO2 and SUMO3 targets are both nuclear and cytoplasmic proteins (Manza et al., 2004
). Cytoplasmic events, such as formation of desmosomal junctions and specific cytoskeletal rearrangements, mark important aspects of keratinocytes differentiation (Hennings and Holbrook, 1983
; Yin and Green, 2004
). Preventing sumoylation by Gam1 expression during HaCaT cell differentiation led to a severe disruption of cell shape, implicating sumoylation as requisite for these morphological changes. A direct cytoplasmic role for SUMO2 and SUMO3 modification may contribute to the dramatic cytoskeletal changes that accompany keratinocyte differentiation.
In conjunction with a possible direct modification of cytoplasmic proteins, the observed increase in sumoylation activity following Ca2+ signaling likely contributes broadly to the keratinocyte differentiation process through effects on nuclear TFs (Fig. 8). A recent publication by Riquelme et al also demonstrated a sumoylation requirement during myogenesis (Riquelme et al., 2006
): when the sumoylation system was inhibited, myoblast fusion-deficient phenotypes were observed. Although in their system they demonstrated an overall decrease of sumoylation during myogenesis, they showed that further decreasing sumoylation using a siRNA to Ubc9 dramatically affected overall myogenic differentiation and cellular fusion. Additionally, Shalizi et al. demonstrated the importance of sumoylation in a neuronal differentiation system. Using granule neurons, they showed that the MEF2 TF is activated through a Ca2+ signaling pathway in these cells, and that sumoylation of MEF2 is necessary to promote differentiation of dendritic claw structures (Shalizi et al., 2006
). Thus, both these studies and our own strongly support an important role for sumoylation in cellular differentiation. Because inactivation of proliferation-enhancing TFs, such as p63 (Ghioni et al., 2005
), has already been shown to be a prerequisite for keratinocyte differentiation, we propose that enhanced sumoylation facilitates this inactivation through direct modification of these or other targets. Ongoing proteomic studies in our laboratory are cataloging and identifying substrates whose sumoylation status changes during HaCaT differentiation (data not shown).
In conclusion, this study identifies sumoylation as a potential regulator in skin biology. Ca2+ signaling stimulates expression of the sumoylation system leading to changes in the sumoylation state of target proteins and allowing proper keratinocyte differentiation. Ca2+ signaling is also an important mediator of lymphocyte activation and differentiation (Freedman, 2006
), oesteoblastic activity and bone formation (Henriksen et al., 2006
), neuronal stem cell development (D'Ascenzo et al., 2006
) and smooth muscle formation (Wamhoff et al., 2006
). Although the intermediate signals are largely unknown for these processes, our work suggests that sumoylation may be modulated in each of these systems through Ca2+-responsive transcription factors. Therefore, the interaction between Ca2+ signaling and the sumoylation system may also be playing a crucial role for proper development of these and other tissues. Lastly, many skin diseases, such as psoriasis, skin cancer (Eckert et al., 2004
) or infections resulting from microbial pathogens (Alfandari et al., 1999
), hijack the normal process of keratinocyte differentiation and lead to abnormal skin formation. If dysregulation of sumoylation is contributing to an aberrant differentiation process, then modulating sumoylation might have therapeutic benefits for the treatment of these diseases.
| Materials and Methods |
|---|
|
|
|---|
RT-PCR and quantitative RT-PCR
All RNAs were extracted using the RNAqueous kit (Ambion). RNA concentration was measured using a spectrophotometer and 5 ng/µl aliquots were stored at -80°C until use. All primers were designed to overlap exon-exon junctions, therefore only amplifying the cDNAs targets and not the genomic sequences (primer sequences are provided in the supplementary material, Tables S1 and S2). The one-step RT-PCR mixture contained 50 ng RNA in a final reaction volume of 25 µl. The mixture also included 2.5 µl of 10x Taq DNA Polymerase buffer (Promega), 50 U MMLV reverse transcriptase, 1 U Platinum Taq (Invitrogen), 4 mM dNTPs, 20 U RNAse OUT (Invitrogen), 6 mM MgCl2 and 0.4 µM of each primer. The one-step RT-PCR was performed for 20 minutes at 42°C for the reverse transcription step, followed by 90 seconds at 94°C, and 40 cycles of amplification (94°C for 30 seconds; 60°C for 30 seconds; 72°C for 60 seconds). Amplifications were performed in a PTC-200 Peltier Thermal Cycler machine (MJ Research). Amplified products were analyzed on 2.5% agarose gels and visualized with an Innotech Alphaimager system (Alpha Innotech). For the quantitative RT-PCR (Q-PCR), one step RT reactions were performed in a single well using 50 ng of harvested RNA in a 50 µl final volume. In addition to the RT components described above, reactions for Q-PCR contained 0.2 µM of LUX primers (designed with the Invitrogen custom primer software), 20 U RNAse OUT, 2 µl of Super Script III enzyme solution (which includes MMLV-RT, Platinum Taq, and dNTPs), and 1 µl Rox dye, all from Invitrogen. The LUX ß-actin primer set (Invitrogen) was used to detect the internal control gene. The PCR reaction conditions for Q-PCR were the same as the RT-PCR described above. The Q-PCR plates were read with an ABI 7500 real-time PCR instrument (Applied Biosystems), and detection of the FAM or JOE label was recorded during the 72°C step. Results were graphed as the fold increase of the relative quantitative RQ values where RQ=2(-
Ct).
Ct was calculated as the average Ct for ß-actin minus the average Ct for the gene of interest, with each sample being run in duplicate. Using the
Ct values from each time point, the 
Ct for each mRNA examined was calculated as the
Ct of the time 0 sample minus the
Ct of time x (in hours) after induction. The data shown are the average from at least three independent RNA preparations collected in separate experiments.
Affinity-purified polyclonal antibodies against Ubc9
Rabbit polyclonal serum 12741 was produced in-house using affinity-purified Ubc9 as the immunogen. A four immunization regime was followed, and 2 weeks after the final boost the rabbit was exsanguinated. To affinity purify anti-Ubc9 antibodies, 750 µg affinity-purified GST-Ubc9 were diluted in a final volume of 500 µl using 1x PBS, and the resulting dilution was dispensed on an 82-mm-diameter, 0.45-µm-pore-size Protran Nitrocellulose filter (Schleicher & Schuell). The membrane was dried for 30 minutes at room temperature, then re-wetted and blocked by incubation at room temperature for 30 minutes in 15 ml of 1x PBS supplemented with 1% BSA. The blocked membrane was incubated for 2 hours at room temperature with 10 ml of a solution containing 2.5 ml of rabbit polyclonal serum 12741 and 7.5 ml of 1x PBS supplemented with 10 mg/ml BSA and 0.05% Tween 20. The membrane was subsequently washed four times each with 15 ml of 1x PBS supplemented with 0.05% Tween 20, and four additional times each with 15 ml of 1x PBS alone. The bound antibodies were eluted by incubation with 2 ml of elution buffer (100 mM glycine, pH 2.5, 0.02% NaN3) for 5 minutes at room temperature. The eluted antibodies were neutralized with 200 µl of 1.0 M Tris-HCl (pH 8.0), aliquoted, and stored at -70°C. The purity of the affinity-purified antibodies was determined by gel electrophoresis and immunoblotting, and its reactivity against Ubc9 was determined by immunoblotting using purified Ubc9 and unfractionated mammalian cell extracts.
Immunohistochemistry
Human foreskin keratinocytes were grown in organotypic raft cultures to form stratified epithelium as previously described (Lambert et al., 2005
). All chemicals used for immunohistochemistry were from Biocare Medical (Concord, CA). Slides were deparaffinized in xylene and rehydrated according to the manufacturer's protocols. The following antibodies and dilutions were used: anti-SUMO serum 12783 (Rosas-Acosta et al., 2005a
), 1:750; affinity purified polyclonal antibodies against Ubc9, 1:20; and polyclonal anti-human keratin 1 (anti-HK1, Covance, Berkeley, CA), 1:5000. Specificity control blocking experiments were performed by adding the corresponding purified proteins (25 µg of Ubc9 or 7 µg of SUMO1) to the cognate antibody dilution. The SUMO and Ubc9 proteins used in the experiments were purified as previously described (Rosas-Acosta et al., 2005a
). After immunostaining, the slides were counterstained with hematoxylin.
Immunoblots and densitometry
Total cell extracts were prepared by adding a 1:1 (v/v) mixture of RIPA buffer (50 mM Tris-HCl, pH 8, 150 mM NaCl, 5 mM EDTA, 15 mM MgCl2, 1% NP40, 0.1% SDS, 1 mM DTT, 1:200 protease inhibitor cocktail and 10 mM N-ethylmaleimide) and 4x sample buffer (100 mM Tris-HCl, pH 6.8, 20% glycerol, 8% SDS, 0.02% bromophenol blue, 4% ß-mercaptoethanol) directly to the cells. The cells were shaken gently for 5-10 seconds, and the resulting lysate was collected by pipetting. Samples were heated at 95°C for 5 minutes and sonicated for 30 seconds using a Misonix sonicator 3000 (Misonix). Samples were resolved on 10% or 12.5% polyacrylamide gels and then transferred onto 0.45 µm Immobilon-P membranes (Millipore). The membranes were blocked for at least 15 minutes with 3% non-fat milk in TTBS (150 mM NaCl, 50 mM Tris-HCl, pH 7.4, 0.005% Tween 20), and incubated for 1 hour or overnight with the primary antibodies listed below at the indicated dilution: rabbit anti
-tubulin (Santa Cruz Biotechnology), 1:15,000; anti-Myc monoclonal antibody (Santa Cruz Biotechnology), 1:500; anti-RanGAP monoclonal antibody (Zymed/Invitrogen Corp.), 1:2500; rabbit serum 12783 against SUMO (Rosas-Acosta et al., 2005b
), 1:1000; affinity-purified polyclonal antibodies against Ubc9, 1:500; anti-human K1 rabbit serum (Covance), 1:1000; anti-SAE1 sheep serum (Axxora), 1:2000; anti-SENP1 rabbit serum (Imgenex), 1:2000; and anti-involucrin rabbit serum (LabVision), 1:1000. After reaction with the primary antibodies, the membranes were incubated with Horseradish Peroxidase-conjugated antibodies (Santa Cruz Biotechnology) at 1:10,000 for 1 hour. The membranes were subsequently rinsed in TTBS, treated with the Western Lightning Chemiluminescence reagent (PerkinElmer Life and Analytical Sciences), and then visualized with X-ray film. Quantitative differences were determined by densitometry using an Innotech Alphaimager (Alpha Innotech) and were normalized to the
-tubulin signal. Quantitative results are the average of at least three separate experiments.
Virus production and infection
Myc-tagged Gam1 adenoviral DNA (Ad-Gam1) was kindly provided by Matt Cotten (GPC-biotech, Munich, Germany). The Ad-Gam1 DNA was transfected into HEK 293A cells using Lipofectamine 2000 (Invitrogen) according to the manufacturer's recommendation. Cells were lysed by freeze-thaw and the supernatant was collected. The initial viral stock was subsequently amplified with two rounds of infection on HEK 293A cells and the final freeze-thaw supernatant collected as the high-titer stock. Adenovirus expressing GFP (Ad-GFP) was kindly provided by G. Davis (Texas A&M Health Science Center, College Station, TX) and amplification was performed as above. Titer was assessed by the limiting-dilution method (Qbiogene Adenovirus Manual, version 1.4) using HEK 293A cells plated at 1x106 cells/well on six-well plates. For adenovirus experiments, HaCaT cells maintained in low [Ca2+] medium were plated at 5x106 in T75 flasks 20 hours before infection. Each culture was infected at an MOI of 300 in 3 ml of Ca2+-free medium supplemented with 8 µg/ml polybrene (Fisher Scientific). Three hours after infection the medium was removed, cells were trypsinized, and released cells were resuspended in 10 ml of high [Ca2+] medium to induce differentiation. The resulting cells suspension was split among the wells of a six-well plate at a ratio such that the cells in each well would achieve approximately 80% confluency by the time of collection. Cells were maintained in high [Ca2+] medium and harvested at various times post plating by direct lysis in the wells using the 1x RIPA:4x sample buffer mixture described above. Proteins were analyzed by immunoblotting as described in the previous section. Cells were visualized by phase contrast and fluorescence microscopy at a magnification of 200x using an Olympus IX70 microscope. Images were captured digitally using a Qcolor3 camera (Olympus).
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Alfandari, J., Magal, S. S., Jackman, A., Schlegel, R., Gonen, P. and Sherman, L. (1999). HPV16 E6 oncoprotein inhibits apoptosis induced during serum-calcium differentiation of foreskin human keratinocytes. Virology 257, 383-396.[CrossRef][Medline]
Arco, P. G. D., Koipally, J. and Georgopoulos, K. (2005). Ikaros SUMOylation: Switching out of repression. Mol. Cell. Biol. 25, 2688-2697.
Ayaydin, F. and Dasso, M. (2004). Distinct in vivo dynamics of vertebrate SUMO paralogues. Mol. Biol. Cell 15, 5208-5218.
Azuma, Y., Tan, S. H., Cavenagh, M. M., Ainsztein, A. M., Saitoh, H. and Dasso, M. (2001). Expression and regulation of the mammalian SUMO-1 E1 enzyme. FASEB J. 15, 1825-1827.
Bikle, D. D., Ng, D., Tu, C. L., Oda, Y. and Xie, Z. (2001). Calcium- and vitamin D-regulated keratinocyte differentiation. Mol. Cell. Endocrinol. 177, 161-171.[CrossRef][Medline]
Boggio, R., Colombo, R., Hay, R. T., Draetta, G. F. and Chiocca, S. (2004). A mechanism for inhibiting the SUMO pathway. Mol. Cell 16, 549-561.[CrossRef][Medline]
Bohren, K. M., Nadkarni, V., Song, J. H., Gabbay, K. H. and Owerbach, D. (2004). A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J. Biol. Chem. 279, 27233-27238.
Bossis, G., Malnou, C. E., Farras, R., Andermarcher, E., Hipskind, R., Rodriguez, M., Schmidt, D., Muller, S., Jariel-Encontre, I. and Piechaczyk, M. (2005). Downregulation of c-Fos/c-Jun AP-1 Dimer activity by sumoylation. Mol. Cell. Biol. 25, 6964-6979.
Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A. and Fusenig, N. E. (1988). Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106, 761-771.
Candi, E., Schmidt, R. and Melino, G. (2005). The cornified envelope: a model of cell death in the skin. Nat. Rev. Mol. Cell Biol. 6, 328-340.[CrossRef][Medline]
Capone, A., Visco, V., Belleudi, F., Marchese, C., Carinali, G., Bellocci, M., Picardo, M., Frati, L. and Torrisi, M. R. (2000). Up-modulation of the expression of functional keratinocyte growth factor receptor induced by high cell density in the human keratinocyte HaCaT cell line. Cell Growth Differ. 11, 607-614.
Chen, A., Mannen, H. and Li, S. S. (1998). Characterization of mouse ubiquitin-like SMT3A and SMT3B cDNAs and gene/pseudogenes. Biochem. Mol. Biol. Int. 46, 1161-1174.[Medline]
Chiocca, S., Kurtev, V., Colombo, R., Boggio, R., Sciurpi, M. T., Brosch, G., Seiser, C., Draetta, G. F. and Cotten, M. (2002). Histone deacetylase 1 inactivation by an adenovirus early gene product. Curr. Biol. 12, 594-598.[CrossRef][Medline]
D'Ascenzo, M., Piacentini, R., Casalbore, P., Budoni, M., Pallini, R., Azzena, G. B. and Grassi, C. (2006). Role of L-type Ca2+ channels in neural stem/progenitor cell differentiation. Eur. J. Neurosci 23, 935-944.[CrossRef][Medline]
Desterro, J. M., Thomson, J. and Hay, R. T. (1997). Ubch9 conjugates SUMO but not ubiquitin. FEBS Lett. 417, 297-300.[CrossRef][Medline]
Desterro, J. M., Rodriguez, M. S. and Hay, R. T. (1998). SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol. Cell 2, 233-239.[CrossRef][Medline]
Eaton, E. M. and Sealy, L. (2003). Modification of CCAAT/enhancer-binding protein-beta by the small ubiquitin-like modifier (SUMO) family members, SUMO-2 and SUMO-3. J. Biol. Chem. 278, 33416-33421.
Eckert, R. L., Crish, J. F., Banks, E. B. and Welter, J. F. (1997a). The epidermis: genes on-genes off. J. Invest. Dermatol. 109, 501-509.[CrossRef][Medline]
Eckert, R. L., Crish, J. F. and Robinson, N. A. (1997b). The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Physiol. Rev. 77, 397-424.
Eckert, R. L., Crish, J. F., Efimova, T. and Balasubramanian, S. (2004). Antioxidants regulate normal human keratinocyte differentiation. Biochem. Pharmacol. 68, 1125-1131.[CrossRef][Medline]
Eichner, R., Sun, T. T. and Aebi, U. (1986). The role of keratin subfamilies and keratin pairs in the formation of human epidermal intermediate filaments. J. Cell Biol. 102, 1767-1777.
Eloranta, J. J. and Hurst, H. C. (2002). Transcription factor AP-2 interacts with the SUMO-conjugating enzyme UBC9 and is sumolated in vivo. J. Biol. Chem. 277, 30798-30804.
Freedman, B. D. (2006). Mechanisms of calcium signaling and function in lymphocytes. Crit. Rev. Immunol. 26, 97-111.[Medline]
Fuchs, E. (1990). Epidermal differentiation: the bare essentials. J. Cell Biol. 111, 2807-2814.
Fuchs, E. and Green, H. (1980). Changes in keratin gene expression during terminal differentiation of the keratinocyte. Cell 19, 1033-1042.[CrossRef][Medline]
Ghioni, P., D'Alessandra, Y., Mansueto, G., Jaffray, E., Hay, R. T., La Mantia, G. and Guerrini, L. (2005). The protein stability and transcriptional activity of p63 alpha are regulated by SUMO-1 conjugation. Cell Cycle 4, 183-190.[Medline]
Gill, G. (2003). Post-translational modification by the small ubiquitin-related modifier SUMO has big effects on transcription factor activity. Curr. Opin. Genet. Dev. 13, 108-113.[CrossRef][Medline]
Girdwood, D. W. H., Tatham, M. H. and Hay, R. T. (2004). SUMO and transcriptional regulation. Semin. Cell Dev. Biol. 15, 201-210.[CrossRef][Medline]
Gong, L. and Yeh, E. T. (2006). Characterization of a family of nucleolar SUMO-specific proteases with preference for SUMO-2 or SUMO-3. J. Biol. Chem. 281, 15869-15877.
Guo, D. H., Han, J. Y., Adam, B. L., Colburn, N. H., Wang, M. H., Dong, Z., Eizirik, D. L., She, J. X. and Wang, C. Y. (2005). Proteomic analysis of SUM04 substrates in HEK293 cells under serum starvation-induced stress. Biochem. Biophys. Res. Commun. 337, 1308-1318.[CrossRef][Medline]
Hennings, H. and Holbrook, K. A. (1983). Calcium regulation of cell-cell contact and differentiation of epidermal cells in culture. An ultrastructural study. Exp. Cell Res. 143, 127-142.[CrossRef][Medline]
Henriksen, Z., Hiken, J. F., Steinberg, T. H. and Jorgensen, N. R. (2006). The predominant mechanism of intercellular calcium wave propagation changes during long-term culture of human osteoblast-like cells. Cell Calcium 39, 435-444.[CrossRef][Medline]
Herwig, S. and Strauss, M. (1997). The retinoblastoma protein: a master regulator of cell cycle, differentiation and apoptosis.